Impax Laboratories (IPXL) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Other (expense) income, net: -373K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Other (expense) income, net: -373K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Impax Laboratories (NASDAQ: IPXL) reported Q2 EPS of $0.18, $0.04 better than the analyst estimate of $0.14. Revenue for the quarter came in at $202.1 million versus the consensus estimate of $195.62 million.
GUIDANCE:
Impax Laboratories sees FY2017 EPS of $0.55-$0.70, versus the consensus of $0.66.
For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08
- Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
